Partnership with Unither Pharmaceuticals to develop a new product to treat pain

January 2017. Unither Pharmaceuticals and Aptys Pharmaceuticals start the development of an innovative product to treat moderate to severe pain  

« We are delighted to collaborate with Aptys Pharmaceuticals, a company well-known in the field of innovative formulation development » declares Eric Goupil, President and CEO of Unither Pharmaceuticals.

« We are very pleased with this partnership with Unither Pharmaceuticals which will bring all its experience in pharmaceutical, clinical and regulatory development» adds François Boutignon, President and CEO of Aptys Pharmaceuticals.

Posted in news.